115 related articles for article (PubMed ID: 2891798)
41. [Benefits of cisplatin-based polychemotherapy in non-small cell bronchogenic carcinoma. Kyushu Lung Cancer Chemotherapy Study Group].
Ohta M; Hara N; Ichikawa Y; Kanda T; Shima K; Tamura K; Hokama M
Gan To Kagaku Ryoho; 1988 Jun; 15(6):1901-8. PubMed ID: 2454615
[TBL] [Abstract][Full Text] [Related]
42. Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine.
Johnson BE; Bridges JD; Sobczeck M; Gray J; Linnoila RI; Gazdar AF; Hankins L; Steinberg SM; Edison M; Frame JN; Pass H; Nesbitt J; Holden D; Mulshine JL; Glatstein E; Ihde DC
J Clin Oncol; 1996 Mar; 14(3):806-13. PubMed ID: 8622028
[TBL] [Abstract][Full Text] [Related]
43. A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B.
Chahinian AP; Propert KJ; Ware JH; Zimmer B; Perry MC; Hirsh V; Skarin A; Kopel S; Holland JF; Comis RL
J Clin Oncol; 1989 Aug; 7(8):993-1002. PubMed ID: 2547030
[TBL] [Abstract][Full Text] [Related]
44. A randomized trial of alternating chemotherapy versus best supportive care in advanced non-small-cell lung cancer.
Cellerino R; Tummarello D; Guidi F; Isidori P; Raspugli M; Biscottini B; Fatati G
J Clin Oncol; 1991 Aug; 9(8):1453-61. PubMed ID: 1649267
[TBL] [Abstract][Full Text] [Related]
45. Randomized trial of radiotherapy to the thorax in limited small-cell carcinoma of the lung treated with multiagent chemotherapy and elective brain irradiation: a preliminary report.
Perez CA; Einhorn L; Oldham RK; Greco FA; Cohen HJ; Silberman H; Krauss S; Hornback N; Comas F; Omura G
J Clin Oncol; 1984 Nov; 2(11):1200-8. PubMed ID: 6092555
[TBL] [Abstract][Full Text] [Related]
46. Benefits and adverse events among elderly patients receiving concurrent chemoradiotherapy for locally advanced non-small cell lung cancer: analysis of the Okayama Lung Cancer Study Group trial 0007.
Takigawa N; Kiura K; Segawa Y; Hotta K; Tamaoki A; Tokuda Y; Nagata T; Watanabe K; Gemba K; Moritaka T; Horita N; Takeda H; Okimoto N; Takemoto M; Matsuo K; Shinkai T; Tabata M; Ueoka H; Kanazawa S; Tanimoto M
J Thorac Oncol; 2011 Jun; 6(6):1087-91. PubMed ID: 21415777
[TBL] [Abstract][Full Text] [Related]
47. Surgical treatment of stage III lung cancer after chemotherapy and radiotherapy.
Lee DY; Kim HK; Paik HC; Kim HJ; Kim SJ
Jpn J Clin Oncol; 1994 Apr; 24(2):101-5. PubMed ID: 8158856
[TBL] [Abstract][Full Text] [Related]
48. [Clinical value of postoperative chemotherapy for non-small cell lung cancer--with special reference to long-term combined chemotherapy combined with immunotherapy].
Watanabe Y; Sato H; Iida S; Yamada T; Kobayashi H; Kimoto H; Tsunamura Y; Ichihashi T; Shimizu J; Hashizume Y
Gan To Kagaku Ryoho; 1985 Jan; 12(1):21-35. PubMed ID: 2981515
[TBL] [Abstract][Full Text] [Related]
49. Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study.
Strauss GM; Herndon JE; Sherman DD; Mathisen DJ; Carey RW; Choi NC; Rege VB; Modeas C; Green MR
J Clin Oncol; 1992 Aug; 10(8):1237-44. PubMed ID: 1321893
[TBL] [Abstract][Full Text] [Related]
50. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group.
Chua DT; Sham JS; Choy D; Lorvidhaya V; Sumitsawan Y; Thongprasert S; Vootiprux V; Cheirsilpa A; Azhar T; Reksodiputro AH
Cancer; 1998 Dec; 83(11):2270-83. PubMed ID: 9840526
[TBL] [Abstract][Full Text] [Related]
51. Adjuvant chemotherapy after radical surgery for non-small-cell lung cancer: a randomized study.
Niiranen A; Niitamo-Korhonen S; Kouri M; Assendelft A; Mattson K; Pyrhönen S
J Clin Oncol; 1992 Dec; 10(12):1927-32. PubMed ID: 1333518
[TBL] [Abstract][Full Text] [Related]
52. Surgical adjuvant chemotherapy in non-small cell lung cancer.
Holmes EC
Semin Oncol; 1988 Jun; 15(3):255-60. PubMed ID: 2837830
[TBL] [Abstract][Full Text] [Related]
53. Chemotherapy for metastatic non-small-cell bronchogenic carcinoma: EST 2575, generation V--a randomized comparison of four cisplatin-containing regimens.
Ruckdeschel JC; Finkelstein DM; Mason BA; Creech RH
J Clin Oncol; 1985 Jan; 3(1):72-9. PubMed ID: 3880810
[TBL] [Abstract][Full Text] [Related]
54. Synergic effect of cisplatin, Adriamycin, and cyclophosphamide combination chemotherapy and radiotherapy in non-small cell lung cancer.
Yoneda S; Honma T; Yoshida S; Min KY; Noguchi Y; Sakura M
Oncology; 1985; 42(1):1-6. PubMed ID: 4038549
[TBL] [Abstract][Full Text] [Related]
55. Role of elective brain irradiation during combined chemoradiotherapy for limited disease non-small cell lung cancer.
Umsawasdi T; Valdivieso M; Chen TT; Barkley HT; Booser DJ; Chiuten DF; Dhingra HM; Murphy WK; Dixon CL; Farha P
J Neurooncol; 1984; 2(3):253-9. PubMed ID: 6389779
[TBL] [Abstract][Full Text] [Related]
56. Combined versus sequential chemo-endocrine therapy in advanced prostate cancer: final results of a randomized Southwest Oncology Group study.
Osborne CK; Blumenstein B; Crawford ED; Coltman CA; Smith AY; Lambuth BW; Chapman RA
J Clin Oncol; 1990 Oct; 8(10):1675-82. PubMed ID: 2213104
[TBL] [Abstract][Full Text] [Related]
57. Surgical adjuvant therapy of non-small-cell lung cancer.
Holmes EC
J Surg Oncol Suppl; 1989; 1():26-33. PubMed ID: 2548520
[TBL] [Abstract][Full Text] [Related]
58. Adriamycin and Cytoxan in the treatment of inoperable lung cancer.
Hoeltgen TM; MacIntyre JM; Perlia CP; Lagakos SW; Stolbach LL; Bennett JM
Cancer; 1983 Jun; 51(11):2005-12. PubMed ID: 6301671
[TBL] [Abstract][Full Text] [Related]
59. New frontiers in the treatment of lung cancer.
Zinreich ES; Baker RR; Ettinger DS; Order SE
Crit Rev Oncol Hematol; 1985; 3(4):279-308. PubMed ID: 2996797
[TBL] [Abstract][Full Text] [Related]
60. Can hypertransfusion attenuate myelosuppression associated with combination chemotherapy in patients with inoperable bronchogenic carcinoma? A report of a randomised, controlled study.
Lam WK; So SY; Ng RP; Yu DY
Med Pediatr Oncol; 1983; 11(5):343-6. PubMed ID: 6355798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
